European Telecoms CEO Warns of US Dominance in Satellites and AI Urges Continent to Recognize Security Risks Nithin Kamath Warns of Inflation Risks From Weak Monsoon and Geopolitical Tensions Kyoto University iPS Cell Research Under Scrutiny Director Labels Work Repetitive Micron Enters 1 Trillion Market Cap Club Amid AIPowered Memory Chip Surge Singapores STI Inches Up 002 as Gainers Outpace Losers Amid Mixed Regional Markets American Consumer Pessimism Persists as Inflation Geopolitical Risks and Trade Policies Weigh on Sentiment BFH Q1 2026 Earnings Strong EPS Beat Amidst Stable Operations Camden National Corporation CAC Q1 2026 Earnings EPS Beat Surprises Amid Regional Banking Headwinds DFTX Q1 2026 Earnings EPS Misses Estimates by 4143 as PreRevenue Biotech Reports Wider Loss ANET Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Stock Climbs PENG Q1 2026 Earnings EPS Surges Past Estimates Stock Gains 248 Arteris Inc AIP Q1 2026 Earnings Narrower Loss Drives Optimistic Start to Fiscal Year BRKRP Preferred Shares Hold Flat at 35688 as Market Awaits Catalysts Averin Capital Acquisition Corp Units ACAAU Hold Steady at 100 Amid Consolidation Bioceres Crop Solutions BIOX Edges Higher Near Key Support Resistance Ahead Coherus Oncology CHRS Rises 37 as Stock Approaches Resistance at 178 Art Technology Acquisition Corp ARTC Holds Near Key Levels with Minimal Price Movement HNB General Insurance Appoints Dilshan Perera as Chief Operating Officer CURR Q3 2025 Earnings Strong EPS Beat Drives Stock Surge LB Pharmaceuticals Inc LBRX Holds Steady Near Resistance as Market Watches for Breakout Duos Technologies DUOT Surges 47 Testing Resistance at 1192 Tower Semiconductor TSEM Rallies 158 as Shares Test Resistance Near 300 Six Flags Entertainment FUN Surges Over 4 Momentum Builds Toward Key Resistance Invesco High Income Trust II VLT Holds Steady Near Support Amidst Mixed Market Conditions Spectral AI Inc MDAI Edges Lower as Stock Consolidates Near Support Zone BioCryst Pharmaceuticals BCRX Surges 626 as Momentum Builds Above Key Support Jazz Pharmaceuticals JAZZ Slips 101 as Biotech Headwinds Weigh on Sentiment